Hjem › Sigdcelleanemi › Michigan
Kliniske studier for Sigdcelleanemi i Michigan
9 studier for Sigdcelleanemi søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
- The Cancer and Hematology Centers (CHC), Grand Rapids
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07656415A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Children's Hospital of Michigan, Detroit
- Great Lakes Research Institute, Flourish Detroit, Southfield
RekruttererFase 2/3
Alder 12 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Central Michigan Children's Hospital of Michigan, Detroit
- Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Detroit Medical Center, Detroit
- Henry Ford Health System, Detroit
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06699849The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of Michigan Health System - Ann Arbor- Site Number : 8400035, Ann Arbor
RekruttererFase 3
Alder 10 til 65 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT06975865Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
- Helen DeVos Children's Hospital, Grand Rapids
RekruttererFase 1/2
1 Day – 21 Years · Alle kjønn · Oppdatert 29. mai 2026 · NCT03128996A Long-term Follow-up Study in Patients Who Received BEAM-101
- Henry Ford Cancer Center, Detroit
RekruttererObservasjonsstudie
Alder 14 til 37 · Alle kjønn · Oppdatert 28. jan. 2026 · NCT07373639Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- The Regents of the University of Michigan, Ann Arbor
Rekrutterer
Alder 16 til 30 · Alle kjønn · Oppdatert 7. jan. 2026 · NCT06374238HPC Offered for PRESERVE Expansion
- Henry Ford Health, Detroit
RekruttererObservasjonsstudie
Alder 12 til 80 · Alle kjønn · Oppdatert 28. aug. 2025 · NCT07145411Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.